GR 89696 fumarate

CAS No. 126766-32-3

GR 89696 fumarate( —— )

Catalog No. M33856 CAS No. 126766-32-3

GR 89696 fumarate is a highly selective κ2 opioid receptor agonist (IC50 = 0.04nM) with anti-pruritchy, anti-injury and neuroprotective effects.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 55 In Stock
10MG 92 In Stock
25MG 152 In Stock
50MG 219 In Stock
100MG 317 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    GR 89696 fumarate
  • Note
    Research use only, not for human use.
  • Brief Description
    GR 89696 fumarate is a highly selective κ2 opioid receptor agonist (IC50 = 0.04nM) with anti-pruritchy, anti-injury and neuroprotective effects.
  • Description
    GR 89696 is a highly selective κ2 opioid receptor agonist with potential to prevent pruritus.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Endocrinology/Hormones
  • Target
    Opioid Receptor
  • Recptor
    Opioid Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    126766-32-3
  • Formula Weight
    530.4
  • Molecular Formula
    C23H29Cl2N3O7
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : ≥ 50 mg/mL (94.27 mM)
  • SMILES
    C(=C/C(O)=O)\C(O)=O.C(CC1=CC(Cl)=C(Cl)C=C1)(=O)N2C(CN3CCCC3)CN(C(OC)=O)CC2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Mei-Chuan Ko, et al. Effects of atypical kappa-opioid receptor agonists on intrathecal morphine-induced itch and analgesia in primates. J Pharmacol Exp Ther. 2009 Jan;328(1):193-200.??
molnova catalog
related products
  • CP 866087

    CP 866087 is an opioid receptor antagonist for the study of female sexual dysfunction.

  • PF-04455242

    PF-04455242 is a potent, selective κ-opioid receptor (KOR) antagonist with Ki of 3 nM/21 nM/22 nM for hKOR/rKOR/mKOR, respectively.

  • Naltrexone hydrochlo...

    A potent, competitive antagonist for μ, κ, δ, and σ-opioid receptors with Ki of 0.0825 nM, 0.509 nM, and 8.02 nM, for MOR, KOR, and DOR, respectively.